Tivicay PD recall: Labeling Error
Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and…
Why was Tivicay PD recalled?
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025
- Product
- Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and…
- Recalling firm
- GlaxoSmithKline LLC
- Quantity
- 463 Cartons
- Distribution
- Nationwide within the United States
- Recall date
- June 12, 2024
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)